0 Yorumlar
0 hisse senetleri
31 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
CIS Insulin Market Evolution: Advancements in Biologic Insulin and Patient-Centric TherapiesThe CIS Insulin Market is witnessing notable growth due to the increasing prevalence of diabetes across Commonwealth of Independent States (CIS) countries, rising healthcare expenditure, and growing awareness regarding diabetes management. Insulin remains one of the most critical therapies for both Type 1 and advanced Type 2 diabetes, making the market highly important for healthcare systems in...0 Yorumlar 0 hisse senetleri 229 Views 0 önizleme
-
Global Dupilumab Drug Market Expected to Reach USD 34.94 Billion by 2032 Amid Rising Demand for Advanced Biologic TherapiesAccording to a report by Intel Market Research, the global Dupilumab Drug Market was valued at USD 16,960 million in 2024 and is projected to reach USD 34,940 million by 2032, registering a CAGR of 11.2% during the forecast period. The market is experiencing substantial growth driven by the increasing prevalence of chronic inflammatory diseases, expanding regulatory approvals, growing adoption...0 Yorumlar 0 hisse senetleri 10 Views 0 önizleme
-
Navigating Novel Modalities: CRO Expertise in Cell, Gene, and Advanced Biologic TherapiesThe rapid scientific advancement in biologics, particularly the groundbreaking field of cell and gene therapy, represents a critical driver for the US contract research sector. These novel therapeutic modalities introduce significant complexity in manufacturing, regulatory submission, and clinical execution that require specialized expertise beyond traditional small-molecule drug trials. CROs...0 Yorumlar 0 hisse senetleri 979 Views 0 önizleme
-
Rising Demand for Orthopedic Drugs Drives Market Growth at 4.7% CAGR Through 2034According to a new report from Intel Market Research, the global prescription orthopedic drugs market was valued at USD 5.8 billion in 2025 and is projected to reach USD 9.1 billion by 2034, growing at a steady CAGR of 4.7% during the forecast period (2026–2034). This sustained growth reflects an aging global population's increasing need for musculoskeletal treatments and continuous...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme